Literature DB >> 12141273

Risperidone may induce mania.

Y Güzelcan1, L de Haan, W F Scholte.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12141273     DOI： 10.1007/s00213-002-1061-y

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  12 in total

1.  Risperidone-induced mania.

Authors:  M Zolezzi; M G Badr
Journal:  Ann Pharmacother       Date:  1999-03       Impact factor: 3.154

2.  Risperidone treatment of refractory acute mania.

Authors:  P J Goodnick
Journal:  J Clin Psychiatry       Date:  1995-09       Impact factor: 4.384

Review 3.  Risperidone.

Authors:  M G Livingston
Journal:  Lancet       Date:  1994-02-19       Impact factor: 79.321

4.  Treatment of refractory rapid cycling bipolar disorder with risperidone.

Authors:  E Vieta; C Gasto; F Colom; A Martinez; A Otero; J Vallejo
Journal:  J Clin Psychopharmacol       Date:  1998-04       Impact factor: 3.153

5.  Manic symptoms induced by olanzapine.

Authors:  L Lykouras; R Gournellis; E Angelopoulos
Journal:  Eur Neuropsychopharmacol       Date:  2001-04       Impact factor: 4.600

6.  A rating scale for mania: reliability, validity and sensitivity.

Authors:  R C Young; J T Biggs; V E Ziegler; D A Meyer
Journal:  Br J Psychiatry       Date:  1978-11       Impact factor: 9.319

7.  Risperidone treatment for juvenile bipolar disorder: a retrospective chart review.

Authors:  J A Frazier; M C Meyer; J Biederman; J Wozniak; T E Wilens; T J Spencer; G S Kim; S Shapiro
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1999-08       Impact factor: 8.829

8.  Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia.

Authors:  S Kapur; R B Zipursky; G Remington
Journal:  Am J Psychiatry       Date:  1999-02       Impact factor: 18.112

9.  Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double-blind comparative study.

Authors:  A Claus; J Bollen; H De Cuyper; M Eneman; M Malfroid; J Peuskens; S Heylen
Journal:  Acta Psychiatr Scand       Date:  1992-04       Impact factor: 6.392

Review 10.  Serotonin-dopamine interaction and its relevance to schizophrenia.

Authors:  S Kapur; G Remington
Journal:  Am J Psychiatry       Date:  1996-04       Impact factor: 18.112
View more
  1 in total

Review 1.  Atypical antipsychotics for the treatment of bipolar disorder: more shadows than lights.

Authors:  Salvatore Gentile
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.